BEDFORD, Mass., May 5 /PRNewswire/ -- Instrumentation Laboratory (IL) today announced total worldwide sales in 2009 of euro 425.3M ($586.4M USD). This represents 11.2% growth v. previous year in current, and 13.2% in local currencies. In the Company's two major business segments, Critical Care and Hemostasis Diagnostics, worldwide growth in local currencies was 13.2% and 12.4%, respectively.
"In spite of the major economic downturn, 2009 was a highly successful year for IL," said Josep Manent, Chief Executive Officer at IL. "Unlike many of our competitors, we were able to achieve significantly greater growth than is typical in a positive economy."
Contributing to IL's success in 2009 was a continuous stream of innovative product offerings. Sales of their flagship Critical Care offering , the GEM Premier 4000 analyzer, grew considerably throughout the world due to its ease of use and its Intelligent Quality Management (iQM®) automated quality assurance system which enhances patient safety and ensures optimal test results. The launch of the new Total Bilirubin assay on the GEM Premier 4000 in Europe, in addition to key new information management enhancements to their GEMweb® Plus Custom Connectivity offering, further propelled its success. Additionally, IL successfully commercialized the GEM Premier 3500 analyzer with iQM in early 2009.
On the Hemostasis side, sales of the ACL TOP® Family of Testing Systems, offering "Testing Process Automation" for enhanced efficiency, grew significantly throughout the world, led by the ACL TOP 500 for mid-size labs. IL also expanded its instrument offering with the launch of the new ACL TOP 700 LAS, designed to meet the needs of highly automated laboratory systems. For the past seven years, the comprehensive HemosIL® line of reagents has consistently dominated the market with the most sophisticated assays for the diagnosis of disease and monitoring of anticoagulant therapy, and in 2009, IL continued this trend. The introduction of several key new assays (e.g., Liquid Heparin), obtaining FDA-clearance for the exclusion of VTE on its D-Dimer HS 500 assay, and the worldwide launch of the Xpert® HemosIL FII & FV assay, solidified IL's position as a leader and innovator in Hemostasis testing solutions.
"For several years, we have maintained double digit growth and in 2009, facing challenging macroeconomic conditions, we successfully continued this trend," said Ramon Benet, Vice President of Worldwide Marketing, US Sales and Service at IL. "Our organic growth is a testament to the confidence our customers place in our products and services; and, to the quality of our products, our people and our strategy."
IL's success in 2009 is visible in its outstanding above-market level of growth, not only in mature markets, but also in new territories, such as China and Latin America. This growth also triggered the acquisition of new facilities in the US, to meet the expanding Manufacturing and R&D demands.
Instrumentation Laboratory (www.ilus.com), founded in 1959, is a worldwide developer, manufacturer and distributor of in vitro diagnostic instruments, related reagents and controls for use primarily in hospitals and independent clinical laboratories. The company's product lines include critical care systems, hemostasis systems and information management systems. IL's GEM® product offerings, part of the critical care line, include the new GEM Premier 3500 with Intelligent Quality Management (iQM®), GEM Premier™ 4000 analyzer, GEMweb Plus Custom Connectivity, and the GEM PCL Plus, a portable coagulation analyzer. IL's hemostasis portfolio includes the ACL TOP® Family of Hemostasis Testing Systems, fully automated, high-productivity analyzers, including the ACL TOP, the new ACL TOP LAS and the ACL TOP 500 CTS. IL also offers the new ACL AcuStar™, ACL ELITE® and ELITE PRO, other hemostasis analyzers and the HemosIL® line of reagents. IL is based in Bedford, Massachusetts.
The Instrumentation Laboratory logo, GEM, GEMweb, iQM, HemosIL, ACL TOP, ACL ELITE, and ACL AcuStar are trademarks of Instrumentation Laboratory Company and/or one of its subsidiaries or parent companies, and may be registered in the United States Patent and Trademark Office and in other jurisdictions. Xpert is a registered trademark of Cepheid. All other product names, company names, marks, logos, and symbols are trademarks of their respective owners.
|SOURCE Instrumentation Laboratory|
Copyright©2010 PR Newswire.
All rights reserved